Allocation of organs, particularly kidneys, within Eurotransplant

Area of Science:

• Nephrology
• Transplantation immunology
• Public health policy

Background:

• Organ scarcity necessitates fair and effective organ allocation systems.
• The Eurotransplant (ET) region implemented a new kidney allocation system in 1996.
• Previous systems faced challenges in optimizing organ distribution and patient outcomes.

Purpose of the Study:

• To evaluate the effectiveness of the Eurotransplant Kidney Allocation System (ETKAS) implemented in 1996.
• To assess the impact of ETKAS on transplant rates for specific patient groups.
• To analyze kidney transplant survival and HLA matching under the new system.

Main Methods:

• Analysis of nearly 30,000 deceased donor kidney allocations over 9 years.
• Evaluation of the ETKAS point-scoring system, including HLA matching, waiting time, and distance.
• Comparison of transplant outcomes before and after ETKAS implementation.

Main Results:

• 22.3% of transplants were HLA-A,B,DR mismatches.
• Transplants for long-waiting (>5 years) patients doubled.
• Increased kidney transplants for children and highly sensitized patients were observed.
• Overall 3-year kidney transplant survival was 78%, with 83% for HLA-A,B,DR mismatched combinations.

Conclusions:

• The ETKAS has successfully met its objectives in improving organ allocation and patient access.
• The system demonstrates positive impacts on transplant rates for vulnerable patient groups.
• The persistent shortage of deceased donor kidneys remains a critical challenge for kidney transplantation.